Vaxcyte, Inc.PCVXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-767M

-65.2% YoY

Free Cash Flow

$-669M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.7B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-104	-232↓124.0%	-468↓101.5%	-570↓21.7%	-924↓62.2%
Net Income	-100	-223↓123.3%	-402↓80.0%	-464↓15.3%	-767↓65.2%
EBITDA	-97	-214↓121.5%	-392↓83.2%	-448↓14.3%	-742↓65.5%
EPS Diluted	-1.93	-3.44↓78.2%	-4.14↓20.3%	-3.80↑8.2%	-5.63↓48.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	69	835↑1109.9%	397↓52.4%	388↓2.4%	174↓55.2%
Total Current Assets	256	943↑267.7%	1,096↑16.3%	1,788↑63.1%	1,627↓9.0%
Total Assets	324	1,006↑210.2%	1,408↑39.9%	3,511↑149.4%	3,046↓13.3%
Total Current Liabilities	29	41↑41.1%	145↑258.6%	140↓3.5%	206↑46.8%
Total Liabilities	40	53↑30.4%	167↑218.6%	205↑22.7%	360↑75.4%
Total Equity	284	954↑235.8%	1,240↑30.1%	3,306↑166.5%	2,686↓18.8%
Total Debt	17	18↑6.9%	29↑62.9%	71↑143.3%	229↑221.8%
Net Debt	-52	-817↓1464.5%	-368↑54.9%	-317↑14.0%	55↑117.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-121	-171↓40.5%	-297↓74.0%	-453↓52.5%	-656↓44.8%
Capital Expenditure	-7	-6↑10.9%	-68↓1062.1%	-22↑67.0%	-14↑38.9%
Free Cash Flow	-128	-176↓37.9%	-365↓106.7%	-475↓30.3%	-669↓40.9%
Stock-Based Comp	11	24↑120.4%	49↑106.2%	85↑74.0%	139↑63.7%
Net Change in Cash	-316	766↑342.0%	-437↓157.1%	-9↑97.9%	-214↓2184.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance